Cancer - Ovarian Cancer

Get Adobe Flash Player to see this content.

Testing For Ovarian Cancer Relapse May Not Work

Using a blood test to detect an ovarian cancer relapse may not help women with the disease live longer, according to a new study.

All Media | Only Audio | Only Video
Sort By: Date | Relevance
Testing For

Testing For Ovarian Cancer Relapse May Not Work

Using a blood test to detect an ovarian cancer relapse may not help women with the disease live longer, according to a new study.

Ovarian Cancer Walk: A Walk for Hope

People came to support awareness of ovarian cancer and the search for a cure.


Ovarian Cancer Walk: A Walk for Hope

People came to support awareness of ovarian cancer and the search for a cure.

Ovarian Cancer Tumors Can Hide for Up to Four Years

A new report says tiny ovarian tumors can reside in a woman's Fallopian tubes for an average of four years before they get large enough to detect.


Ovarian Cancer Patients Can Maintain Fertility

Taking every opportunity to preserve an ovarian cancer patient's fertility does not hurt her chance of survival, according to a new study.

Breast Cancer: Dr. Nancy and Dr. Susan Love Help Raise Awareness

Breast Cancer: Dr. Nancy and Dr. Susan Love Help Raise Awareness

Dr. Nancy Snyderman talks with Meredith Vieira and Dr. Susan Love as part of "Breast Cancer Today" and the start of breast cancer awareness month.


Lynch Syndrome

Lynch Syndrome

A new test for Lynch Syndrome can help determine if you are at a higher risk for colon and other cancers.

Preventative Surgery is Popular Among Women

Preventative Surgery is Popular Among Women

Many women are opting to have breasts and ovaries surgically removed if they're found to be at high risk for cancer.


A New Drug Attacks Cancer Tumors Safely

A New Drug Attacks Cancer Tumors Safely

A new cancer drug attacks a tumor's DNA without harming healthy cells.

Cervarix Has Been Approved by the FDA

Cervarix Has Been Approved by the FDA

The FDA has approved a second cervical cancer vaccine called Cervarix. It will compete with Merck's Gardasil shot.